Patent classifications
A61F2013/0091
PROCESSING OF CHEMICALLY MODIFIED CELLULOSIC FIBRES
A chemically modified cellulosic fibre or filament having a moisture content of at least 7% by weight obtained by a process comprising the steps of (i) obtaining cellulosic fibres or filament and chemically modifying the cellulose by substitution to increase its absorbency; (ii) washing the fibres after step (i) in a mixture comprising water and up to 99% by weight of water-miscible organic solvent; (iii) drying the fibres to a moisture content of at least 7% by weight.
Medical dressing
A medical dressing (30) is disclosed, comprising an adhesive layer (3) having a skin-facing surface (6) to adhere the medical dressing to a dermal surface, wherein said adhesive layer comprises a first chemical compound incorporated within said adhesive layer, and wherein at least a portion of said skin-facing surface comprises a coating (9) comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.
Antiseptic wound dressing
The antiseptic wound dressing includes at least nanometer chitin, alkaline earth metal alginate, and an antiseptic material. The nanometer chitin is tubular shaped having diameter 1050 nm and length 20200 nm. The amount of the nanometer chitin is 0.1%5% to the alkaline earth metal alginate. The antiseptic wound dressing is manufactured by mixing nanometer chitin and alkaline metal alginate, further mixing with antiseptic material, conducting a wet spinning process to produce fibers, and conducting a non-woven cloth process to obtain the antiseptic wound dressing of the present invention. Therefore, the antiseptic wound dressing is capable of reducing the chance of would infection, and providing superior moisture retention and enhanced wet strength.
MEDICAL DRESSING
A dressing is used for curing a wound, and includes a dressing body having a first plane to make contact with a wound of a patient and a second plane opposite to the first surface, a display unit provided on the second plane to display information, and having a flexibility, and a light irradiation device to apply light the wound of the patient. The light irradiation device includes a device board, at least one light emitting diode mounted on the device board, and a water-proof protective film provided on the light emitting diode to protect the light emitting diode.
EXPANDABLE COMPRESSION BANDAGE FOR HEMOSTASIS
The present invention is directed to an expandable compression bandage. The expandable compression bandage includes: an adhesive bandage part; and a pressing part including a solvent storage part and an expandable part. The solvent storage part is configured to be attached to a part of an adhesive surface of the adhesive bandage part and to store a swelling solvent, and the expandable part is configured to be disposed beneath the solvent storage part. The expandable part is swollen and expanded when the swelling solvent stored in the solvent storage part is absorbed thereinto.
ABSORBING MEMBER STORING APPARATUS
The present invention relates to an absorbing member storing apparatus, and includes a first storing part (110) in which an absorbing member is stored, a second storing part (120), and a fastening part (130). The fastening part (130) is formed inside the first storing part (110), and the second storing part is fitted into the fastening part (130). According to the present invention, through the opening of the storing apparatus in which an absorbing member and a fluid have been separately stored, the absorbing member, such as sterilized cotton, a sterilized cotton swab, or the like, can be immediately wet with the fluid, thereby enabling the significantly hygienic and convenient storage and use of an absorbing member.
Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
SELF CONTAINED WOUND DRESSING APPARATUS
The composite wound dressing apparatus promotes healing of a wound via the use of a vacuum pump. The vacuum pump applies a vacuum pressure to the wound to effectively draw wound fluid or exudate away from the wound bed. The vacuum pump is tethered to the wound dressing and is portable, preferably, carried by the patient in a support bag, which permits patient mobility. Moreover, the patient does not need to be constrained for any period of time while exudate is being removed from the wound.
MULTIFUNCTIONAL FORMULATION COMPRISED OF NATURAL INGREDIENTS AND METHOD OF PREPARATION/MANUFACTURING THEREOF
This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phytopharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
ANTISEPTIC WOUND DRESSING
The antiseptic wound dressing includes at least nanometer chitin, alkaline earth metal alginate, and an antiseptic material. The nanometer chitin is tubular shaped having diameter 1050 nm and length 20200 nm. The amount of the nanometer chitin is 0.1%5% to the alkaline earth metal alginate. The antiseptic wound dressing is manufactured by mixing nanometer chitin and alkaline earth metal alginate, further mixing with antiseptic material, conducting a wet spinning process to produce fibers, and conducting a non-woven cloth process to obtain the antiseptic wound dressing of the present invention. Therefore, the antiseptic wound dressing is capable of reducing the chance of would infection, and providing superior moisture retention and enhanced wet strength.